Is there a particular program that is of interest to you, or is it mainly their platform that you like?
They seem to have a deep pipeline but I'm not sure why MACK should merit a ~$600M market cap. One could point to several innovative oncology-focused biotechs with similarly deep pipelines trading for half that valuation IMHO.